¼¼ºê¶õ½º ¾È°úº´¿ø °³¿ø 4Áֳ⠱â³ä ½ÉÆ÷Áö¿ò – Updates on Thyroid Eye Disease : 2023-09-02
±³À°ÀÏÀÚ : 2023-09-02
±³À°Àå¼Ò : ¼¼ºê¶õ½ºº´¿ø º»°ü 6Ãþ Àº¸í´ë°´ç
±³À°ÁÖÁ¦ : ¼¼ºê¶õ½º ¾È°úº´¿ø °³¿ø 4Áֳ⠱â³ä ½ÉÆ÷Áö¿ò – Updates on Thyroid Eye Disease
ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú
´ã´çÀÚ : ÀÎÀº¹Ì
¿¬¶ôó : 02-2228-3570
À̸ÞÀÏ : opth@yuhs.ac
±³À°Á¾·ù : ¾È°ú
Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í Àü°øÀÇ 3¸¸¿ø / ÇöÀå 4¸¸¿øÀü¹®ÀÇ 6¸¸¿ø / ÇöÀå 7¸¸¿ø»çÀüµî·Ï ÆäÀÌÁö : http://severanceeye.theplanix.com/
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 09:00~09:10 Biolipid in TED ¼À¯¸®(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 09:10~09:20 Applicating machine learning in TED ¹ÚÁ¤·Ä(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 09:20~09:30 Novels serologic biomarkers in TED À̹ÎÁ¤(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 09:30~09:40 ER stress on inflammation, adipogenesis, and fibrosis in TED °íÀç»ó(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 09:40~09:50 Tear-derived exosome protein in TED ¹éÁö¼±(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 09:50~10:00 Perfecting organoids application in oculoplastics À¯Çý¸°(Â÷ÀÇ°ú´ë)
Åä·Ð 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 10:00~10:15 Discussion ()
ÈÞ½Ä 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 10:15~10:30 Break ()
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 10:30~10:50 Image guided management in TED Kelvin Kam-Lung Chong(The Chinese University of Hong Kong(CUHK))
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 10:50~11:10 Novel biologics experience in TED Don O. Kikkawa(Shiley Eye Institute, University of California at San Diego(UCSD))
Åä·Ð 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 11:10~11:25 Discussion ()
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 11:25~11:40 Stabilizing thyroid function and antibody ½Åµ¿¿±(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 11:40~11:50 Risk factors for TED progression ÀÌÈ(°í·ÁÀÇ´ë)
Åä·Ð 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 11:50~12:00 Discussion ()
ÈÞ½Ä 09¿ù 02ÀÏ 12:00~13:30 Lunch & Photo ()
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 13:30~13:40 Orbital fat decompression À±Áø¼÷(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 13:40~13:50 Balanced orbital wall decompression ÀÌÁ¤±Ô(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 13:50~14:00 Inferomedial orbital wall decompression »çÈ£¼®(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 14:00~14:10 Endonasal orbital decompression °¼º¸ð(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 14:10~14:20 Eyelid retraction repair ¾çÀç¿í(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 14:20~14:30 Discussion ()
ÈÞ½Ä 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 14:30~14:45 ()
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 14:45~14:55 Radiotherapy for Type I TED ÃÖÈñ¿µ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 14:55~15:05 Management of dysthyroid optic neuropathy À̼ºº¹(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 15:05~15:15 Ocular surface problems in TED ¼ÕÁØÇõ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 15:15~15:25 Thyroid cancer and TED Àå¼±¿µ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 15:25~15:35 Selenium in TED management ±è³²ÁÖ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 15:35~15:45 Pediatric TED ÀÌ°¡Çö(°Ç¾çÀÇ´ë)
Åä·Ð 09¿ù 02ÀÏ ¼¼ºê¶õ½ºº´¿ø 6ÃþÀº¸í´ë°´ç 15:45~16:00 Discussion ()